Skip to main navigation Skip to search Skip to main content

Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson's disease

  • Saurav Brahmachari
  • , Saebom Lee
  • , Sangjune Kim
  • , Changqing Yuan
  • , Senthilkumar S. Karuppagounder
  • , Preston Ge
  • , Rosa Shi
  • , Esther J. Kim
  • , Alex Liu
  • , Donghoon Kim
  • , Stephan Quintin
  • , Haisong Jiang
  • , Manoj Kumar
  • , Seung Pil Yun
  • , Tae In Kam
  • , Xiaobo Mao
  • , Yunjong Lee
  • , Deborah A. Swing
  • , Lino Tessarollo
  • , Han Seok Ko
  • Valina L. Dawson, Ted M. Dawson
  • Johns Hopkins University
  • Adrienne Helis Malvin Medical Research Foundation
  • Diana Helis Henry Medical Research Foundation
  • National Institutes of Health

Research output: Contribution to journalArticlepeer-review

Abstract

α-Synuclein misfolding and aggregation plays a major role in the pathogenesis of Parkinson's disease. Although loss of function mutations in the ubiquitin ligase, parkin, cause autosomal recessive Parkinson's disease, there is evidence that parkin is inactivated in sporadic Parkinson's disease. Whether parkin inactivation is a driver of neurodegeneration in sporadic Parkinson's disease or a mere spectator is unknown. Here we show that parkin in inactivated through c-Abelson kinase phosphorylation of parkin in three α-synuclein-induced models of neurodegeneration. This results in the accumulation of parkin interacting substrate protein (zinc finger protein 746) and aminoacyl tRNA synthetase complex interacting multifunctional protein 2 with increased parkin interacting substrate protein levels playing a critical role in α-synuclein-induced neurodegeneration, since knockout of parkin interacting substrate protein attenuates the degenerative process. Thus, accumulation of parkin interacting substrate protein links parkin inactivation and α-synuclein in a common pathogenic neurodegenerative pathway relevant to both sporadic and familial forms Parkinson's disease. Thus, suppression of parkin interacting substrate protein could be a potential therapeutic strategy to halt the progression of Parkinson's disease and related α-synucleinopathies.

Original languageEnglish
Pages (from-to)2380-2401
Number of pages22
JournalBrain
Volume142
Issue number8
DOIs
StatePublished - 1 Aug 2019
Externally publishedYes

Keywords

  • PARIS
  • Parkinson's disease
  • parkin
  • zinc finger protein 746
  • α-synuclein

Fingerprint

Dive into the research topics of 'Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson's disease'. Together they form a unique fingerprint.

Cite this